וינקריסטין טבע

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

VINCRISTINE SULFATE

MAH:

ABIC MARKETING LTD, ISRAEL

ATC_code:

L01CA02

pharmaceutical_form:

תמיסה להזרקה

composition:

VINCRISTINE SULFATE 1 MG/ML

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

therapeutic_group:

VINCRISTINE

therapeutic_area:

VINCRISTINE

therapeutic_indication:

Vincristine may be used either as sole agent or in combination therapy in the treatment of acute leukemias. malignant lymphomas including Hodgkin's disease lymphosarcoma and reticulum cell sarcoma, neuroblastoma, Wilm's tumor, rhabdomyosarcoma.

authorization_date:

2015-02-28